<?xml version="1.0" encoding="UTF-8"?>
<p id="Par12">With the addition of oral chemotherapy to radiotherapy, similar results were observed. Snipstad et al
 <italic>.</italic>
 <sup>
  <xref ref-type="bibr" rid="CR34">34</xref>
 </sup> (GSE15781) evaluated the RNA expression of nine patients’ rectal cancer tissue before and 4–6 weeks after pre-operative chemoradiotherapy of 50 Gy in 25 fractions over 5 weeks with capecitabine 825 mg/m
 <sup>2</sup> administered twice daily during radiotherapy. We investigated the expression of these same viral entry genes, and observed that 4–6 weeks after chemoradiotherapy, there was a reduction of 
 <italic>ACE2</italic> (
 <italic>p</italic> = 0.02) and 
 <italic>TMPRSS2</italic> (
 <italic>p</italic> = 0.01), but continued increase in 
 <italic>CTSL</italic> expression (
 <italic>p</italic> = 0.006) (Fig. 
 <xref rid="Fig6" ref-type="fig">6</xref>).
</p>
